Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma.
Luo X, Chen A, Qin L, Weinkove R, Zhao R, Ye T, Chen S, Tang J, Liu J, Huang J, Shi B, Yuan D, Tan H, Qin D, Tang Z, Li P, Zheng R.
Luo X, et al. Among authors: ye t.
Front Immunol. 2024 Dec 9;15:1497736. doi: 10.3389/fimmu.2024.1497736. eCollection 2024.
Front Immunol. 2024.
PMID: 39717765
Free PMC article.